vancomycin has been researched along with Psoriasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbatiello, B; Ajami, NJ; Belkaid, Y; Chen, Q; Chen, W; Chen, ZJ; Chia, C; Jiao, X; Kasagi, S; Konkel, JE; Nakatsukasa, H; Petrosino, JF; Smith, DP; Wu, R; Zanvit, P; Zhang, D | 1 |
| Al-Hommos, NA; Bakri, FG; Cui, L; Hiramatsu, K; Naffa, RG; Shehabi, A | 1 |
| Bergman, R; Friedman-Birnbaum, R; Sprecher, E | 1 |
3 other study(ies) available for vancomycin and Psoriasis
| Article | Year |
|---|---|
Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis.
Topics: Aminoquinolines; Animals; Animals, Newborn; Anti-Bacterial Agents; Disease Susceptibility; Drug Interactions; Imiquimod; Interleukin-17; Interleukin-22; Interleukins; Mice; Mice, Inbred C57BL; Microbiota; Polymyxin B; Psoriasis; Skin; T-Lymphocytes; Vancomycin | 2015 |
Persistent bacteraemia due to methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in a patient with erythrodermic psoriasis.
Topics: Anti-Bacterial Agents; Bacteremia; Humans; Male; Methicillin Resistance; Middle Aged; Psoriasis; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Cyclosporine treatment of psoriatic erythroderma complicated by bacterial sepsis.
Topics: Acitretin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Psoriasis; Sepsis; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1999 |